We are live on ! Find out more
RXST icon

RxSight
RXST

40 hedge funds and large institutions have $75M invested in RxSight in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 7

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

3% more funds holding

Funds holding: 39 → 40 (+1)

4.63% less ownership

Funds ownership: 29% → 24.37% (-4.6%)

25% less capital invested

Capital invested by funds: $100M → $75M (-$25.4M)

Holders
40
Holders Change
+1
Holders Change %
+2.56%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
19
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SC
Sessa Capital
New York
+$1.97M
2
O
OrbiMed
New York
+$1.6M
3
BlackRock
BlackRock
New York
+$550K
4
Russell Investments Group
Russell Investments Group
United Kingdom
+$525K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$498K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$11.4M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$6.46M
3
Millennium Management
Millennium Management
New York
-$1.31M
4
CCM
CAAS Capital Management
New York
-$1.27M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$839K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$34.3M – – –
O
2
OrbiMed
New York
$15.6M +$1.6M +133,500 +11%
BlackRock
3
BlackRock
New York
$4.45M +$550K +45,747 +13%
Vanguard Group
4
Vanguard Group
Pennsylvania
$3.8M -$839K -69,795 -17%
MF
5
Magnetar Financial
Illinois
$2.86M -$328K -27,277 -10%
Millennium Management
6
Millennium Management
New York
$2.49M -$1.31M -108,597 -33%
SC
7
Sessa Capital
New York
$1.85M +$1.97M +164,282 New
RI
8
RTW Investments
New York
$1.69M – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$1.37M +$498K +41,454 +51%
State Street
10
State Street
Massachusetts
$1.21M +$208K +17,307 +19%
Northern Trust
11
Northern Trust
Illinois
$843K +$50.2K +4,179 +6%
Russell Investments Group
12
Russell Investments Group
United Kingdom
$490K +$525K +43,648 New
BFM
13
Boothbay Fund Management
New York
$475K -$131K -10,909 -21%
Wells Fargo
14
Wells Fargo
California
$379K +$87.2K +7,259 +28%
IWM
15
IHT Wealth Management
Illinois
$376K +$219K +18,250 +120%
BFS
16
Bradley Foster & Sargent
Connecticut
$352K +$7.15K +595 +2%
State of Wisconsin Investment Board
17
State of Wisconsin Investment Board
Wisconsin
$281K – – –
E
18
Ergoteles
New York
$273K +$292K +24,293 New
Allspring Global Investments
19
Allspring Global Investments
North Carolina
$263K +$281K +23,396 New
Charles Schwab
20
Charles Schwab
California
$255K +$29.5K +2,457 +12%
State of Tennessee, Department of Treasury
21
State of Tennessee, Department of Treasury
Tennessee
$226K +$91.3K +7,600 +61%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$195K +$24.8K +2,065 +14%
Boston Partners
23
Boston Partners
Massachusetts
$171K +$183K +15,185 New
Bank of America
24
Bank of America
North Carolina
$152K +$114K +9,457 +235%
GCM
25
Ghisallo Capital Management
Massachusetts
$113K – – –
1
2

RXST Hedge Fund Activity: Q4 2021 in Review

40 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q4 2021, worth a combined $75M — down 25% from $100M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new RXST positions and 4 closed out — a net gain of 2 holders — while 19 added to existing stakes and 7 trimmed.

The largest buyer was Sessa Capital, opening a new position worth an estimated $1.97M. The largest seller was Deerfield Management, exiting entirely with an estimated $11.4M sold.

  • 40 institutional investors held RxSight (RXST) as of Q4 2021, up from 39 in Q3 2021.
  • Funds reported $75M of RxSight stock for Q4 2021, down 25% quarter-over-quarter.
  • 6 funds opened new RxSight positions in Q4 2021 and 4 closed out, a net change of +2 holders.
  • The largest RxSight buyer in Q4 2021 was Sessa Capital, an estimated $1.97M added.
  • The largest RxSight seller in Q4 2021 was Deerfield Management, an estimated $11.4M sold.

Based on aggregated 13F filings for Q4 2021.